Profiling of Circulating Tumor Cells for Screening of Selective Inhibitors of Tumor‐Initiating Stem‐Like Cells

A critical barrier to effective cancer therapy is the improvement of drug selectivity, toxicity, and reduced recurrence of tumors expanded from tumor‐initiating stem‐like cells (TICs). The aim is to identify circulating tumor cell (CTC)‐biomarkers and to identify an effective combination of TIC‐spec...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chia‐Lin, Hernandez, Juan Carlos, Uthaya Kumar, Dinesh Babu, Machida, Tatsuya, Tahara, Stanley M., El‐Khoueiry, Anthony, Li, Meng, Punj, Vasu, Swaminathan, Suresh Kumar, Kirtane, Ameya, Chen, Yibu, Panyam, Jayanth, Machida, Keigo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10190641/
https://www.ncbi.nlm.nih.gov/pubmed/36949364
http://dx.doi.org/10.1002/advs.202206812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10190641/
https://www.ncbi.nlm.nih.gov/pubmed/36949364
http://dx.doi.org/10.1002/advs.202206812

Ejemplares similares